bioRxivImmunologyPreprint
Antibody-mediated depletion of select T cell subsets in blood and tissue of nonhuman primates
M. S. Sutton, A. N. Bucsan, C. C. Lehman, M. Kamath, S. Pokkali, D. M. Magnani, R. Seder, P. A. Darrah, M. Roederer
Abstract
Understanding the immunological control of pathogens requires a detailed evaluation of the mechanistic contributions of individual cell types within the immune system. While knockout mouse models that lack certain cell types have been used to help define the role of those cells, the biological and physiological characteristics of mice do not necessarily recapitulate that of a human. To overcome some of these differences, studies often look towards nonhuman primates (NHPs) due to their close phylogenetic relationship to humans. To evaluate the immunological role of select cell types, the NHP model provides distinct advantages since NHP more closely mirror the disease manifestations and immunological characteristics of humans. However, many of the experimental manipulations routinely used in mice (e.g., gene knock-out) cannot be used with the NHP model. As an alternative, the in vivo infusion of monoclonal antibodies that target surface proteins on specific cells to either functionally inhibit or deplete cells can be a useful tool. Such depleting antibodies have been used in NHP studies to address immunological mechanisms of action. In these studies, the extent of depletion has generally been reported for blood, but not thoroughly assessed in tissues. Here, we evaluated four depleting regimens that primarily target T cells in NHP: anti-CD4, anti-CD8, anti-CD8{beta}, and immunotoxin-conjugated anti-CD3. We evaluated these treatments in healthy unvaccinated and IV BCG-vaccinated NHP to measure the extent that vaccine-elicited T cells - which may be activated, increased in number, or resident in specific tissues - are depleted compared to resting populations in unvaccinated NHPs. We report quantitative measurements of in vivo depletion at multiple tissue sites providing insight into the range of cell types depleted by a given mAb. While we found substantial depletion of target cell types in blood and tissue of many animals, residual cells remained, often residing within tissue. Notably, we find that animal-to-animal variation is substantial and consequently studies that use these reagents should be powered accordingly.
- organism: non-human primate
- assay: flow cytometry
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CD4 T cells and CD8α+ lymphocytes are necessary for intravenous BCG-induced protection against tuberculosis in macaques
Andrew W. Simonson, Joseph John Zeppa, … JoAnne L. Flynn·The Journal of Experimental MedicinePeer-reviewed·Feb 6, 2025
- Deep phenomics of African green monkey and Baboon PBMCs using a 30-marker spectral flow cytometry panel
Soumik Barman, Arsh Patel, … David J Dowling·bioRxiv·Nov 9, 2026
- Depletion and recovery of IgG following treatment with Rozanoliximab and Imlifidase in pigtail macaques
Kara M. Rzasa, Joanna Zikos, … Margaret E. Ackerman·bioRxiv·Nov 11, 2025
- Permanent lymphocyte subset elimination upon a single dose of AAV-delivered depletion antibody dissects immune control of chronic viral infection
Anna Lena Kastner, Anna‐Friederike Marx, … Daniel D. Pinschewer·ImmunityPeer-reviewed·Dec 24, 2024
- PD-1 Specific 'Blocking' Antibodies That Deplete PD-1+ T Cells Present An Inconvenient Variable In Pre-clinical Immunotherapy Experiments
F. Polesso, M. W. Munks, … A. E. Moran·bioRxiv·Apr 14, 2020
- TRAIL-mediated PMN-MDSC depletion prevents CD4+ T cell loss in HIV-infectedhumanized mice
Shawn A. Abeynaike, Kayla Frank, … Silke Paust·bioRxiv·Jan 22, 2025